These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 8124251

  • 1. Measurement of recipient-specific alloreactivity: is GVHD predictable?
    Theobald M, Bunjes D, Nierle T, Arnold R, Heimpel H.
    Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
    [Abstract] [Full Text] [Related]

  • 2. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 3. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Theobald M, Nierle T, Bunjes D, Arnold R, Heimpel H.
    N Engl J Med; 1992 Dec 03; 327(23):1613-7. PubMed ID: 1435898
    [Abstract] [Full Text] [Related]

  • 4. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL, Atasoylu AA.
    Bone Marrow Transplant; 1991 Jul 03; 8(1):51-8. PubMed ID: 1833016
    [Abstract] [Full Text] [Related]

  • 5. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY, Kwok J, Lie AK, Chen P, Chen FE, Liang R.
    Haematologica; 2001 Jun 03; 86(6):652-6. PubMed ID: 11418376
    [Abstract] [Full Text] [Related]

  • 6. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
    Russell CA, Heilmann C, Madsen HO, Vindeløv LL.
    Bone Marrow Transplant; 2001 May 03; 27(9):949-58. PubMed ID: 11436105
    [Abstract] [Full Text] [Related]

  • 7. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 03; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 8. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.
    Laurin D, Hannani D, Pernollet M, Moine A, Plumas J, Bensa JC, Cahn JY, Garban F.
    Transfusion; 2010 Feb 03; 50(2):418-28. PubMed ID: 19843288
    [Abstract] [Full Text] [Related]

  • 9. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM, Kessler FL, Verdonck LF, Stadhouders-Keet SA, van Lier RA, de Gast GC, Otten HG.
    Br J Haematol; 2000 Dec 03; 111(3):791-6. PubMed ID: 11122139
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxic T lymphocyte precursor (CTL-p) frequency analysis in unrelated donor bone marrow transplantation: two case studies.
    Kaminski ER, Hows JM, Bridge J, Davey NJ, Brookes PA, Green JE, Goldman JM, Batchelor JR.
    Bone Marrow Transplant; 1991 Jul 03; 8(1):47-50. PubMed ID: 1912955
    [Abstract] [Full Text] [Related]

  • 11. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA.
    Bone Marrow Transplant; 1997 May 03; 19(10):1001-9. PubMed ID: 9169644
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A, Amar A, Brautbar C, Condiotti R, Lazarovitz V, Nagler A.
    Exp Hematol; 1995 Dec 03; 23(14):1667-75. PubMed ID: 8542963
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation.
    MacMillan ML, Radloff GA, Kiffmeyer WR, DeFor TE, Weisdorf DJ, Davies SM.
    Transplantation; 2003 Dec 27; 76(12):1758-62. PubMed ID: 14688528
    [Abstract] [Full Text] [Related]

  • 20. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E.
    Nat Med; 1999 Jul 27; 5(7):839-42. PubMed ID: 10395333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.